Equities

Beijing Konruns Pharmaceutical Co Ltd

603590:SHH

Beijing Konruns Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)24.87
  • Today's Change0.07 / 0.28%
  • Shares traded1.94m
  • 1 Year change-36.25%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue920867810
OPERATING EXPENSES
Cost of revenue total101127106
Selling, general and admin. expenses, total582519476
Depreciation/amortization262622
Unusual expense(income)320.94(0.01)
Other operating expenses, total(11)(13)(7.34)
Total operating expense796726617
Operating income124141192
Other, net(0.75)(0.37)(3.41)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes123140189
Provision for income taxes(65)1621
Net income after taxes188124167
Minority interest(37)(22)(19)
Net income before extra. Items150101148
Total extraordinary items------
Net income150101148
Inc.avail. to common excl. extra. Items150101148
Inc.avail. to common incl. extra. Items150101148
EPS RECONCILIATION
Basic/primary weighted average shares159156157
Basic/primary eps excl. extra items0.950.650.94
Basic/primary eps incl. extra items0.950.650.94
Dilution adjustment------
Diluted weighted average shares159156157
Diluted eps excl. extra items0.950.650.94
Diluted eps incl. extra items0.950.650.94
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.300.200.30
Gross dividend - common stock4800
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental2.780.861.41
SUPPLEMENTAL INCOME
Depreciation, supplemental363632
Total special items320.960.01
NORMALISED INCOME
Normalized income before taxes154141189
Effect of special items on income taxes110.110.00
Income tax excluding impact of special items(54)1721
Normalized income after tax208125167
Normalized income avail. to common171102148
Basic normalized EPS1.080.650.94
Diluted normalized EPS1.080.650.94
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.